EUVIMEDEUVIMED entdecken
Open Access

Predicted Risk of Ventricular Arrhythmias in a Genome-First Population With Genetic Risk for Arrhythmogenic Right Ventricular Cardiomyopathy

Eric D Carruth iD, Brittney Murray iD, Crystal Tichnell iD, Katelyn Young iD, Hugh Calkins iD, Cynthia A James iD, Christopher M Haggerty iD

Circulation: Arrhythmia and Electrophysiology · 2025

DOI: 10.1161/circep.124.013231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2025. Verfasst von Eric D Carruth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Health (E.D.C.), Geisinger, Danville, PA. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Tachycardia, Ventricular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Population genomic screening for desmosome variants associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) may facilitate early disease detection and protective intervention. The validated ARVC risk calculator offers a novel means to risk stratify individuals with diagnosed ARVC, but predicted risk in the context of genomic screening identification has not been explored. METHODS: Individuals harboring a pathogenic/likely pathogenic variant in a desmosome gene ( PKP2 , DSP , DSG2 , or DSC2 ) were identified through the Geisinger MyCode Genomic Screening and Counseling program. The ARVC risk calculator was applied to patients with a subsequent evaluation of right ventricular function. This predicted risk was compared with outcomes in the first 5 years (range, 0.3–5.0 years) after genetic result return. RESULTS: Of 254 individuals with a clinically confirmed pathogenic/likely pathogenic desmosome variant, 113 (median age, 56 [interquartile range, 42–66]; 71% female) had cardiac imaging in follow-up and no prior sustained ventricular arrhythmia (VA). Eighty-two (73%) had no ARVC task force criteria (TFC) besides the variant (possible diagnosis), 22 (19%) had a single additional minor criterion (borderline diagnosis), and 9 (8%) met criteria for definite diagnosis. The median 5-year predicted VA risk was 3.9% (2.3%–6.6%), notably lower than that of the calculator derivation cohort (20.6%). The risk of fast VA was 1.6% (1.0%–2.9%). The predicted VA risk was higher in individuals with any nongenetic ARVC task force criteria (6.3% [2.5–13.2%]) versus those without (3.7% [2.2–5.6%]; P =0.01), and in individuals with DSP variants (6.1% [3.9–7.8%] versus PKP2 3.4% [2.2–5.3%]; P =0.01). Over a median 3.0 years of follow-up (≤5 years only), no sustained VA events were observed in this cohort. CONCLUSIONS: The predicted 5-year risk of VA in individuals ascertained via population genomic screening for desmosome variants is low (3.9%; 1.6% for fast VA) but may vary by affected gene and ARVC task force criteria burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmogenic Right Ventricular DysplasiaTachycardia, VentricularHumansFemaleMaleMiddle AgedAdultRisk AssessmentGenetic Predisposition to DiseaseAgedPlakophilinsDesmoglein 2DesmocollinsRisk FactorsGenetic TestingDesmoplakinsDesmosomesPhenotypePredictive Value of Tests

Stichwörter der Autor:innen

cardiomyopathiesdefibrillatorsdesmosomesgenotyperisk

Substanzen

PlakophilinsDesmoglein 2DSC2 protein, humanPKP2 protein, humanDesmocollinsDSG2 protein, humanDesmoplakinsDSP protein, human

Autor:innen und Institutionen

  • Department of Genomic Health (E.D.C.), Geisinger, Danville, PA.
  • Division of Cardiology, Department of Medicine, Johns Hopkins Medical Center, Baltimore, MD (B.M., C.T., H.C., C.A.J.).
  • Heart and Vascular Institute (K.Y.), Geisinger, Danville, PA.
  • Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY (C.M.H.).

ORCID-Profile: Eric D Carruth, Brittney Murray, Crystal Tichnell, Katelyn Young, Hugh Calkins, Cynthia A James, Christopher M Haggerty

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Carruth, E. D., Murray, B., Tichnell, C., Young, K., Calkins, H., James, C. A., & Haggerty, C. M. (2025). Predicted Risk of Ventricular Arrhythmias in a Genome-First Population With Genetic Risk for Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.124.013231

Vancouver

Carruth ED, Murray B, Tichnell C, Young K, Calkins H, James CA, et al. Predicted Risk of Ventricular Arrhythmias in a Genome-First Population With Genetic Risk for Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation: Arrhythmia and Electrophysiology. 2025. doi:10.1161/circep.124.013231

BibTeX
@article{Carruth2025,
  author = {Carruth, Eric D and Murray, Brittney and Tichnell, Crystal and Young, Katelyn and Calkins, Hugh and James, Cynthia A and Haggerty, Christopher M},
  title = {Predicted Risk of Ventricular Arrhythmias in a Genome-First Population With Genetic Risk for Arrhythmogenic Right Ventricular Cardiomyopathy},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2025},
  doi = {10.1161/circep.124.013231}
}
Kostenlos starten →